A phase II trial of trastuzumab plus weekly ixabepilone (BMS-247550) and carboplatin in patients with HER/neu-positive metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2014
At a glance
- Drugs Ixabepilone (Primary) ; Trastuzumab (Primary) ; Carboplatin
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Apr 2011 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.